The DOI matches its Crossref record; 131 of the 132 references it cites were found in a registry or an index.
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease
Abstract
Alzheimer's disease (AD) is the most common dementing disorder of late life. Although there might be various different triggering events in the early stages of the disease, they seem to converge on a few characteristic final pathways in the late stages, characterized by inflammation and neurodegeneration. In this review, we revisit the hypothesis that advanced glycation endproducts (AGEs) and their receptor RAGE may play an important role in disease pathogenesis. Accumulation of AGEs in cells and tissues is a normal feature of aging, but is accelerated in AD. In AD, AGEs can be detected in pathological deposits such as amyloid plaques and neurofibrillary tangles. AGEs explain many of the neuropathological and biochemical features of AD such as extensive protein crosslinking, glial induction of oxidative stress and neuronal cell death. Oxidative stress and AGEs initiate a positive feedback loop, where normal age-related changes develop into a pathophysiological cascade. RAGE and its decoy receptor soluble RAGE, may contribute to or protect against AD pathogenesis by influencing transport of β-amyloid into the brain or by manipulating inflammatory mechanisms. Targeted pharmacological interventions using AGE-inhibitors, RAGE-antagonists, RAGE-antibodies, soluble RAGE or RAGE signalling inhibitors such as membrane-permeable antioxidants may be promising therapeutic strategies to slow down the progression of AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oxidative stress can also be generated due to AGE formation in the brain. This feed-forward process creates a vicious cycle that exacerbates oxidative damage with the subsequent initiation and progression of neurodegenerative diseases4,103.”
From Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury (2021) · cites this paper as [103]
In the citing paper
“In the brain, AGEs can be produced as a result of elevated oxidative stress during aging or chronic exposure to toxic agents such as alcohol (ethanol), n-6 fatty acid-containing high-fat Western diets, and sugary soft drinks.”
From Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury (2021) · cites this paper as [103]
Citations
Cites
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature reviews. Immunology · doi:10.1038/nri1594 · Cited by 2,490
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
Donato, R. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00046-2 · Cited by 1,580
Neeper, M. P., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y., Elliston, K. O., Stern, D., & SHAW, A. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,545
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,426
Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
Hickman, S. E., Allison, E. K., & El Khoury, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0616-08.2008 · Cited by 1,329
Advanced protein glycosylation in diabetes and aging
Brownlee, M. D. (1995) · Annual Review of Medicine · doi:10.1146/annurev.med.46.1.223 · Cited by 1,312
Research works printed but not linked: 2
- Dukic-Stefanovic, 2003, Signal transduction pathways in mouse microglia N-11 cells activated by advanced glycation endproducts (AGEs), J. Neurochem., 87, 44, 10.1046/j.1471-4159.2003.01988.x · DOI
- Yan, 1996, RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease, Nature, 382, 685, 10.1038/382685a0 · DOI · Paper page
Cited by
Sorted by citations
Items 401–500 of 526
Gu, B., Bu, Y., Hao, Z., Song, M., & Chen, J. (2025) · European journal of medical research · doi:10.1186/s40001-025-03522-2 · Cited by 5
“These processes simultaneously activate microglia, triggering neuroinflammatory responses [34–36].”
An anti-RAGE chimeric antibody alleviates CCl4-induced liver fibrosis via RAGE/NF-kB pathway in mice
Liu, J., Li, H., Chen, H., Xiao, X., Jin, Z., Paerhati, P., Bao, W., Cui, C., Zhu, J., & Yuan, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117737 · Cited by 5
Murakami, Y., Fujino, T., Kurachi, R., Hasegawa, T., Usui, T., Hayase, F., & Watanabe, H. (2018) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2018.1475213 · Cited by 5
“The AGEs-RAGE axis is associated with the pathogenesis and development of multiple chronic diseases such as diabetic complications and neurodegenerative diseases [5].”
BackgroundYou, S., Jang, M., & Kim, G. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.104996 · Cited by 5
Postprandial Light Exercise Attenuates the Glycemic Effect of a Candy Bar
Heiss, C. J., & Tollefson, M. (2014) · Topics in Clinical Nutrition · doi:10.1097/01.tin.0000445897.59899.48 · Cited by 5
Pearce, K. L., Hatzinikolas, A., Moran, L., de Courten, M., Forbes, J. M., Scheijen, J. L. J. M., Schalkwijk, C. G., Walker, K. Z., & de Courten, B. V. (2017) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2017.1319468 · Cited by 5
“…body of evidence suggests that AGEs, both formed within the body and those ingested, are significant pathogenic mediators contributing to a number of chronic diseases including diabetes (Tan et al. 2011), cardiovascular disease (Hegab et al. 2012) and Alzheimer’s dementia (Srikanth et al. 2011).”
BackgroundHuang, J.-L., Feng, Y.-Q., Bai, L., Qin, M.-C., Xu, Z., Liu, Z., Chen, W., Wu, D., & Zhong, Z.-G. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/8469754 · Cited by 5
“There are reports showing that oxidative stress contributes to Aβ generation either by downregulating the lowdensity lipoprotein receptor-related protein 1 (LRP-1) and upregulating the receptor for advanced glycation end products (RAGE) or by increasing the activity of β- and γsecretases [30].”
BackgroundZhou, J., Li, X., Wang, Y., Zhang, Y., Jia, X., Fan, J., Zhang, Q., Hu, F., & Li, W. (2021) · Journal of Carbohydrate Chemistry · doi:10.1080/07328303.2021.1921786 · Cited by 5
“It is accompanied by many diseases, such as atherosclerosis, kidney disease, diabetes, and Alzheimer’s disease.([2,3]) It is widely accepted that oxidative”
BackgroundElectrochemical Aptasensors for Parkinson’s Disease Biomarkers Detection
Mikuła, E., Katrlı́k, J., & Rodrigues, L. R. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220520123337 · Cited by 5
S., C. A. T., Mendes, T. D. O., dos Santos, L., Silva, M. G. P., Pereira, L., Fávero, P. P., Singh, P., & Martin, A. A. (2018) · Vibrational Spectroscopy · doi:10.1016/j.vibspec.2018.10.005 · Cited by 6
Berberine mitigates methotrexate-induced oxidative stress and inflammation in the cerebrum of rats
Hozayen, W. G., Ramadan, S. M., Fadel, A., & Mahmoud, A. M. (2017) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2017.71106 · Cited by 5
Fu, W., Lu, R., Wang, D., & Sang, Z. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.110044 · Cited by 4
Son, S., Arai, M., Toriumi, K., Andica, C., Matsuyoshi, D., Kamagata, K., Aoki, S., Kawashima, T., Kochiyama, T., Okada, T., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-39379-w · Cited by 4
Hao, S., Ye, M., Li, N., Lu, Z., Quan, W., Xu, H., & Li, M. (2024) · Food Research International · doi:10.1016/j.foodres.2024.114811 · Cited by 5
Ouerdane, Y., El-Nahas, Z. S., Ouerdane, F., Hamam, K. M., & Ebada, M. A. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_12 · Cited by 4
Recent Treatment Strategies in Alzheimer's Disease and Chronic Traumatic Encephalopathy
Lucke-Wold, B. P. (2022) · Biomedical Research and Clinical Reviews · doi:10.31579/2692-9406/128 · Cited by 4
“This provides another clue as to why aging is a risk factor for AD [88,89,92].”
BackgroundWatanabe, M., Toyomura, T., Wake, H., Nishinaka, T., Hatipoğlu, Ö. F., Takahashi, H. K., Nishibori, M., & Mori, S. (2023) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2538 · Cited by 4
Bayoumy, N. M. K., EL-SHABRAWI, M., & NADA3, H. (2013) · Archives of Rheumatology · doi:10.5606/tjr.2013.2845 · Cited by 4
“Since RAGE induction is under the effect of AGEs, the RAGE-AGEs pathway is thought to be incriminated in the pathogenesis of these diseases.[20,21]”
Radix Achyranthis Bidentatae improves learning and memory capabilities in ovariectomized rats.
Wang, Y.-F., Xu, Y., Pan, Y., Li, W., Zhang, W., Liu, Y., Jia, J., & Li, P. (2013) · PubMed Central · doi:10.3969/j.issn.1673-5374.2013.18.002 · Cited by 4
“Our experimental findings are consistent with the results of Srikanth et al [66].”
ResultPolyphenolic Compounds with Anti-Ages Activity from Three Clusiaceae Plants
Magadula, J. J., Mbwambo, Z. H., Gatto, J., Derbré, S., Guilet, D., & Richomme, P. (2014) · European Journal of Medicinal Plants · doi:10.9734/ejmp/2014/10812 · Cited by 4
“In various types of cells, the transcription of NF-kB regulated genes induces an inflammation process [7] and pathological changes [8].”
BackgroundThe Biology of Aging: Implications for Diseases of Aging and Health Care in the Twenty‐First Century
Watt, D. F. (2014) · Wiley eBooks · doi:10.1002/9781118730676.ch1 · Cited by 4
Kamel, W. A., Haghi, M., Khosroshahi, H. T., & Dehghan, G. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10846-z · Cited by 3
Yang, W., Yong, S., Zhang, W., Zhou, Q., Tan, X., & Xu, Y. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111635 · Cited by 3
Takei, S., Ochi, M., Shiraoka, A., Matsumoto, S., Fujishita, S., Okada, Y., Miura, S., Ochi, H., Igase, M., & Ohyagi, Y. (2024) · Archives of Gerontology and Geriatrics Plus · doi:10.1016/j.aggp.2024.100071 · Cited by 3
Stentz, F. B. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.94427 · Cited by 3
Pericytes and the Neurovascular Unit: The Critical Nexus of Alzheimer Disease Pathogenesis?
Cercy, S. P. (2021) · Exploratory Research and Hypothesis in Medicine · doi:10.14218/erhm.2020.00062 · Cited by 4
Improving mouse models for the study of Alzheimer's disease
Reagan, A. M., Onos, K. D., Heuer, S. E., Sasner, M., & Howell, G. R. (2022) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2021.12.005 · Cited by 5
Singh, A., Ansari, V. A., Mahmood, T., Ahsan, F., & Wasim, R. (2023) · Current Cosmetic Science · doi:10.2174/2666779702666230220111250 · Cited by 3
Effect of Cerebralcare Granule® combined with memantine on Alzheimer's disease
Yang, M., Zhang, X., Qiao, O., Zhang, J., Li, X., Ma, X., Zhou, S., & Gao, W. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117609 · Cited by 3
Phyo, S. H., Siddique, M. S., Mushtaq, A., Yiasmin, M. N., Alahmad, K., Khan, I., Ghamry, M., & Zhao, W. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.106818 · Cited by 3
Abou‐Raya, A., Kamel, M. A. E.-N., Sayed, E. A. G., & El-Sharkawy, A. A. H. (2015) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2015.06.005 · Cited by 3
“Since RAGE induction is under the effect of AGEs, the RAGE-AGEs pathway is thought to be incriminated in the pathogenesis of these diseases.(20,21) Receptor for advanced glycation end products is a receptor for a family of about 20 related calcium binding proteins that are only expressed in vertebrates.”
BackgroundDiabetes Associated Memory Impairment: Perspective on Management Strategies
Sharma, G., Sonu, & Harikumar, S. (2015) · International journal of pharma research and review · Cited by 3
Planque, S. A., Massey, R. J., & Paul, S. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.111188 · Cited by 3
“The misfolding process is accelerated by age-associated metabolic disturbances, for example, increased generation of advanced glycation and lipid peroxidation end products (Butterfield et al., 2010; Srikanth et al., 2011).”
BackgroundSzutowicz, A. (2015) · Diagnostyka Laboratoryjna · doi:10.5604/01.3001.0008.2261 · Cited by 3
Watanabe, M., Toyomura, T., Wake, H., Liu, K., Teshigawara, K., Takahashi, H. K., Nishibori, M., & Mori, S. (2018) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1706 · Cited by 3
Epigenetic contributions to cancer: Exploring the role of glycation reactions
Khan, H., Rafi, Z., Khan, M. Y., Maarfi, F., Rehman, S., Kaur, K., Ahmad, M. K., Shahab, U., Ahmad, S., & Ahmad, S. (2024) · International review of cytology · doi:10.1016/bs.ircmb.2024.04.001 · Cited by 2
Koike, S., Kajiki, H., Kamegai, M., Kayama, T., & Ogasawara, Y. (2026) · NeuroToxicology · doi:10.1016/j.neuro.2026.103444 · Cited by 2
Bai, X., Zhang, G., Xiao, X., Zeng, Q., Zhao, Y., Wang, P., Long, F., & Liu, W. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01678-3 · Cited by 3
Alzheimer Disease and Dementia
AYDIN, A. C. (2020) · Journal of Literature Pharmacy Sciences · doi:10.5336/pharmsci.2019-71813 · Cited by 3
Dementia Is Induced via the AGEs/Iba1/iNOS Pathway in Aged KK-Ay/Tajcl Mice
Hiramoto, K., Imai, M., Tanaka, S., & Ooi, K. (2023) · Life · doi:10.3390/life13071540 · Cited by 2
“Microglia and astrocytes in the brain contain RAGE, a receptor for AGEs, and the number of patients with AD is increasing compared to healthy elderly people [9,17].”
BackgroundKhan, J., & Tatlı, I. İ. (2023) · Springer eBooks · doi:10.1007/978-981-99-3848-3_8 · Cited by 2
Putallaz, P., Seematter‐Bagnoud, L., Draganski, B., Rouaud, O., Krief, H., & Büla, C. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-05025-x · Cited by 2
“Indeed, some of these mechanisms have also been reported in Alzheimer’s disease [8, 9].”
BackgroundEffects of glycaemic control on memory performance, hippocampal volumes and depressive symptomology
Sevim, G. Y., Alkan, E., Taporoski, T. P., Krieger, J. E., Pereira, A. C., & Evans, S. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01429-2 · Cited by 2
“Elevated cortisol has been associated with poor glycaemic control, and the hippocampus is highly sensitive to the neurotoxic effects of cortisol [23]; glucotoxic-ity due to hyperglycaemia may also contribute, through the build-up of AGEs [19, 20].”
BackgroundKrištofíková, Z., Říčný, J., Šírová, J., Řı́pová, D., Lubitz, I., & Beeri, M. S. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1654-6 · Cited by 2
“In the brain tissue of AD patients, colocalization of AGE products and nNOS [24] or AGE products and iNOS [25] have been found.”
BackgroundHeiss, C. J., & Goldberg, L. R. (2015) · Obesity Research - Open Journal · doi:10.17140/oroj-2-113 · Cited by 2
Koroev, D. O., Volpina, O. M., Volkova, T. D., Kamynina, A. V., Филатова, М. П., Balasanyants, S. M., Samokhin, A. N., & Бобкова, Н. В. (2017) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162017020066 · Cited by 2
The role of d-galactose in the aging heart and brain
Bo‐Htay, C., Shwe, T., Chattipakorn, S. C., & Chattipakorn, N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-849886-6.00022-7 · Cited by 2
Carbohydrate and Protein Metabolism: Influences on Cognition and Alzheimer's Disease
Fernando, W. M. A. D. B., Gupta, V. B., Jayasena, V., Brennan, C. S., & Martins, R. N. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch6 · Cited by 2
Bhattacharya, I., Bhattacharya, T., Sahu, A., Das, P., Sarkar, S., Prasanna, V. S., Sreed, R., Ravichandiran, V., & Arumugam, S. (2024) · Research Square · doi:10.21203/rs.3.rs-4667019/v1 · Cited by 2
Bhargavan, B., Annadurai, N., & Kanmogne, G. D. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02197-4 · Cited by 1
“This increase in RAGE correlated with RAGE-Aβ colocalization, increased CNS Aβ 42 , and severe AD pathology [74, 119, 130], and was associated with increased Aβ 42 CNS influx, pTau, neuroinflammation, and neurodegeneration [36, 116].”
Lu, Z., Hao, S., Yan, H., Li, N. N., Hu, J., Quan, W., Cheng, J., Xu, H. R., & Li, M. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c11716 · Cited by 1
Romeo, M., Barzago, M. M., Fracasso, C., Nettis, M., Riva, A., Gobbi, M., Tongiani, S., & Diomede, L. (2026) · Pharmaceuticals · doi:10.3390/ph19040525 · Cited by 1
“We also assessed QF’s ability to reduce the accumulation of advanced glycation end products (AGEs), which are considered markers of senescence [25–27], and to modify the expression of genes encoding components of the IIS pathway.”
Shapiro, A. L. B., Thangthaeng, N., DeSanto, K., Bettcher, B. M., & Killeen, A. A. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10061-6 · Cited by 1
“Glycated proteins, lipids, and amino acids are shown to directly damage neural tissue, with extensive in vivo evidence of their role in cortical neuron apoptosis and broad neurotoxicity via neuroinflammation [ 50, 51], which contribute to neurodegenerative disease [12, 13, 51, 52].”
Ramos, N., Heiss, C. J., Sikalidis, A. K., Avila, J. T., & Rompicharla, R. (2026) · Journal of the American Nutrition Association · doi:10.1080/27697061.2026.2678431 · Cited by 1
Lee, H., Buongiorno, P. A., Tam, C. C., Shukitt‐Hale, B., & Yokoyama, W. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107454 · Cited by 1
RAGE and Its Ligands in Melanoma
Leclerc, E. (2015) · InTech eBooks · doi:10.5772/59172 · Cited by 1
“[92] Srikanth V, Maczurek A, Phan T, Steele M, Westcott B, Juskiw D, et al.”
BackgroundMultifaceted Role of Matrix Metalloproteases on Human Diseases
Roy, S., Pramanik, A., Chakraborti, T., & Chakraborti, S. (2017) · Springer eBooks · doi:10.1007/978-981-10-3162-5_2 · Cited by 2
“Activation of the receptor for AGE (RAGE) causes release of proinflammatory cytokines and free radicals which contributes to inflammatory processes [16].”
BackgroundBiomarkers of Oxidative Stress in Parkinson’s Disease
Fernández‐Espejo, E. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622888-00423 · Cited by 1
Immunopathogenesis of Alzheimer’s disease, Parkinson’s Disease, and other Neurodegenerative Diseases
Kumar, S., Shukla, A. K., Yadav, V. K., Srivastava, A., Dwivedi, D., & Singh, S. P. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815238754124010006 · Cited by 1
Role of oxidative stress in Alzheimer's disease and related consequences
Chmátalová, Z., & Skoumalová, A. (2014) · Klinická biochemie a metabolismus · doi:10.61568/kbm.2014.031 · Cited by 1
Point of View about Erythropoietin in Treatment of Central Nervous System Diseases
Yang, L. Z., Li, R. L., Wu, B., Luo, J., Chen, Z., Ping, X., Yan, & Tan, W. (2017) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000320 · Cited by 1
Neurocognitive and Neuropsychological Effects of OSA
Spector, A. R., & Farrer, T. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-54146-0_4 · Cited by 1
The analysis of advanced glycation endproducts
Scheijen (2017) · Research Publications (Maastricht University) · doi:10.26481/dis.20170621js · Cited by 1
Rock, C. A., Keeney, S. J., Zakharchenko, A., Takano, H., Spiegel, D. A., Krieger, A. Μ., Ferrari, G. M., & Levy, R. J. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.28.117739 · Cited by 1
Doppen, P. (2007) · Utrecht University Repository (Utrecht University) · Cited by 1
Juvekar, A. R., Daroi, P. A., & Dhage, S. N. (2022) · Research Square · doi:10.21203/rs.3.rs-1406225/v1 · Cited by 1
Iturria‐Medina, Y., Poole, V. N., Zammit, A. R., Yu, L., Tasaki, S., Hong, J. H., Lopes, K. D. P., Batalha, C. M. P. F., Ridwan, A. R., Vialle, R. A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.20.644323 · Cited by 1
“…noteworthy, as they—such as advanced glycation end products (AGEs)—can accumulate in neural tissues and are associated with neurodegeneration. amyloid-β For instance, the presence of AGEs in amyloid-β plaques and neurofibrillary tangles can exacerbate oxidative stress and neuronal death (27, 28) .”
Cicco, E. D. (2010) · Unicam Scientific Publications (University of Camerino)
Bayoumy, N. M. K., El-Shabrawi, M., & Nada, H. (2013)
Antidiabetic effect of potential Indian medicinal plants: A target specific in-vitro study
Kaur, G., Ali, Z., & Yagnambhatla, R. (2014)
Editorial: Molecular Mechanism of Neuronal Dysfunction in the Diabetic Brain
Goalstone, M. L., & Pugazhenthi, S. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00045
“Chronic hyperglycemia-induced accumulation of advanced glycation end products (AGEs) (4) and their receptor RAGE are among the mechanistic links between diabetes and AD (5).”
BackgroundKrishnan, S., & Rani, P. (2016) · International Journal of Bioinformatics Research and Applications · doi:10.1504/ijbra.2016.078226
Morbus Alzheimer – Ansätze für die Prävention und Therapie
Friedrichsen, H.-P. (2017) · Erfahrungsheilkunde · doi:10.1055/s-0043-104514
“Der Anteil von Neuronen und Gliazellen mit AGEEinlagerung bei Alzheimer-Patienten steigt mit dem Fortschreiten der Erkrankung und ist mit dem Anstieg oxidativer und inflammatorischer Prozesse verbunden [13].”
BackgroundChoudhury, A., Chakraborty, I., Banerjee, T. S., Vana, D. R., Adapa, D., & Arun Kumar, R. (2018) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000360
“Microglial activation triggers the receptor for advanced glycoxidation end-products (RAGE), which is responsible for sensing Aβ [51].”
BackgroundRose, K. N. (2019) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/diss-rose-kenneth-2019
Farooqui, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819603-8.00010-9
Insulin resistance, dementia, and depression
Farooqui, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819603-8.00008-0
Gore, S. S. (2019) · KU ScholarWorks (The University of Kansas)
Bourgognon, J.-M., Spiers, J. G., Robinson, S., Scheiblich, H., Ortori, C. A., Bradley, S. J., Tobin, A. B., & Steinert, J. R. (2020) · doi:10.21203/rs.3.rs-20075/v1
“The production of AGE following TPI nitrotyrosination is directly linked to the activation of the receptor for AGE (RAGE) and the expression of RAGE reflects a positive confirmation for AGE signaling [47].”
BackgroundThe ketogenic diet revisited - evaluation of the ketogenic diet in neurological disorders
Yıldız, D., & Scheurink, A. J. W. (2016)
Ramírez, U. A. T., Medina, M. E., Ruiz, A. P. R., Borja, M. D. L. Á. S., & Ricoy, O. U. D. (2021) · Lux Médica · doi:10.33064/48lm20212964 · Cited by 1
PYRAZOLINE CONTAINING MOLECULES AS MULTIFUNCTIONAL AGENTS IN ALZHEIMER’S DISEASE
Khambete, M., Murumkar, P. R., Kumar, A., Darreh‐Shori, T., De, S., Yadav, M. R., & Degani, M. S. (2019) · INDIAN DRUGS · doi:10.53879/id.56.10.12104
Perspective Chapter: Alzheimer - A Complex Genetic Background
Calabrò, M., & Crisafulli, C. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101455
Mecanismos de dano celular e envelhecimento humano
Sgarbieri, V. C., Pacheco, M. T. B., Gibrim, N. F., de Oliveira, D. A. G., & Caetano‐Silva, M. E. (2021) · Editora da Unicamp eBooks · doi:10.7476/9788526815353.0003
The Multifaceted Roles of Ketogenic Diets in Neurology-Brain Cancers and Other Neurologic Diseases
Binsaeedu, A. S., Khalifa, M., & Tan-Shalaby, J. L. (2023) · Recent Progress in Nutrition · doi:10.21926/rpn.2302007
Inhibition of AGEs-RAGE-PP2A axis alleviates cognitive impairment after chronic heart failure
Li, S., Wang, L., Wang, J., 梁碧荣, Gao, W., Huang, Y., Deng, B., Liu, Q., Zhou, Z., Zhang, L., et al. (2023) · Cellular and Molecular Biology · doi:10.14715/cmb/2023.69.5.28
“Some neurological research revealed that AGE-RAGE axis stimulation can lead to tau hyperphosphorylation and Aβ deposition (9), which induce neurofibrillary tangles (NFTs) and senile plaques (SP), two characteristic pathologic changes of cognitive impairment.”
BackgroundAging—the most important collagen neoepitope?
LAURSEN, C. F. G., Genovese, F., & Karsdal, M. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15617-5.00041-x
Nutrition in the pathogenesis of metabolic syndrome: Roles of sugar, salt and fat
Banik, S. P., Downs, B. W., Kushner, S. W., Ghosh, R. B., Chakraborty, S., Bagchi, M., & Bagchi, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85732-1.00009-8 · Cited by 1
Neurotoxicity induced by glycotoxins
Lidia de, B. A. R. I., Sukach, V. A., & Kalapos, M. P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00077-4
Ding, B., Lin, C., Liu, Q., He, Y., Ruganzu, J. B., Jin, H. Z., Peng, X., Ji, S., Ma, Y., & Yang, W. (2020) · Figshare · doi:10.6084/m9.figshare.13093892
Gök, S., Okyar, B., Tuncel, D. A., Tolun, F. İ., Baylan, F. A., Acıpayam, C., Doğaner, A., & Çetin, G. Y. (2024) · Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi · doi:10.17517/ksutfd.1287352
Manual de Medicina Interna Vol. 6
Verduga, M. D. F. N., Vélez, K. E. C., Guaman, J. D. R., Mendoza, H. N. G., Sánchez, L. M. C., Guajala, R. G. Y., & Vera, A. G. M. (2024) · doi:10.56470/978-9942-660-78-7
Paul, G., Remya, N., Unnikrishnanan, M., Baby, R. E., & Baby, P. (2025) · doi:10.38124/ijisrt/25jul1968
Diet and Dementia Worldwide: The Role of Meat Fat, Meat Protein, and Development Indicators
You, W., & Feng, S. (2025) · Journal of dementia and Alzheimer's disease · doi:10.3390/jdad2040043 · Cited by 1
“These compounds disrupt vascular and neuronal integrity, amplify oxidative stress, and accelerate amyloid and tau pathology, reinforcing the plausibility of fat-related risk [16,63].”
Introduction to confluence of diabetes and Alzheimer's disease
Anju, T. R., Sunny, S., & Malat, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-40559-4.00011-8
Metadata
- Authors
- Srikanth, V., Maczurek, A., Phan, T., Steele, M., Westcott, B., Juskiw, D., & Münch, G.
- Affiliations
- Monash University (AU)
- Western Sydney University (AU)
- James Cook University (AU)
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 32
- Issue
- 5
- Pages
- 763-777
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2027183895
- Cited by
- 524
- References
- 132
- Citations by year
- 2026: 20 · 2025: 25 · 2024: 31 · 2023: 25 · 2022: 34 · 2021: 46 · 2020: 32 · 2019: 43 · 2018: 26 · 2017: 46 · 2016: 33 · 2015: 39 · 2014: 38 · 2013: 26 · 2012: 32
- FWCI
- 2.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Neurobiology of Aging (publishedVersion)
- PubMed (publishedVersion)
- ResearchOnline at James Cook University (James Cook University) (submittedVersion)
- Funders
- National Health and Medical Research Council (436797, 491109)
- Alzheimer's Australia
- Deutsche Forschungsgemeinschaft (Mu 1011/14-1, Mu1011/15-1)
- Alzheimer Forschung Initiative
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- advanced glycation end products, RAGE, Alzheimer's disease, soluble RAGE, amyloid plaques, neurofibrillary tangles, oxidative stress, neuroinflammation, neurodegeneration, protein cross-linking, RAGE antagonists, AGE inhibitors, pathogenesis
- MeSH terms
- Receptor for Advanced Glycation End Products, Aging, Alzheimer Disease, Diabetes Mellitus, Type 2, Humans, Macrophages, Receptors, Immunologic, Neurofibrillary Tangles, Glycation End Products, Advanced, Microglia, Oxidative Stress, Disease Progression, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review